Francisco García-Rio1, Joan B Soriano2, Marc Miravitlles3, Luis Muñoz4, Enric Duran-Tauleria5, Guadalupe Sánchez6, Victor Sobradillo7, Julio Ancochea8. 1. Servicio de Neumología, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain. Electronic address: fgr01m@gmail.com. 2. Fundación Caubet-CIMERA Illes Balears, Bunyola, Illes Balears, Spain; CIBER de Enfermedades Respiratorias, Madrid, Spain. 3. Fundació Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain. 4. Pneumology Department, Hospital Reina Sofía, Córdoba, Spain. 5. IMIM/CREAL, Barcelona, Spain. 6. Medical Department, GlaxoSmithKline SA, Madrid, Spain. 7. Pneumology Department, Hospital de Cruces, Bilbao, Spain. 8. Servicio de Neumología, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IP), Madrid, Spain.
Abstract
BACKGROUND: The current debate about the lower limit of normal (LLN) vs the 0.7 fixed ratio to diagnose COPD is not completely resolved, and little information about the clinical impact of these different criteria is available. We compared differences in health-related quality of life, exacerbations, exercise tolerance, physical activity, comorbidity, and systemic biomarkers of subjects with FEV(1)/FVC < 0.7 but > LLN (ratio-only group) vs subjects without COPD and those with mild or moderate to severe COPD. METHODS: A population-based sample of 3,802 subjects aged 40 to 80 years from the Epidemiologic Study of COPD in Spain was selected. Subjects were evaluated with postbronchodilator spirometry, quality-of-life and physical activity questionnaires, and 6-min walk tests. Exacerbations within the previous year and comorbidities were recorded. Systemic biomarkers were measured after excluding subjects with conditions associated with systemic inflammatory processes. RESULTS: Fixed-ratio COPD overdiagnosis affects up to 4.6% of subjects aged 40 to 80 years, is more frequent in men, and increases with age. After adjusting for confounding factors, the ratio-only group had a worse health-related quality of life than the non-COPD group, with poorer scores in all questionnaire domains (P < .05). However, no differences between the two groups for respiratory exacerbations, 6-min walk distance, physical activity, or systemic biomarkers were observed. Ratio-only subjects did not present greater risk for cardiovascular disease (adjusted relative OR, 1.47; 95% CI, 0.81-2.64), whereas subjects with mild COPD did (adjusted relative OR, 2.32; 95% CI, 1.11-4.84). CONCLUSIONS: Subjects receiving a diagnosis of COPD by the fixed ratio present worse self-reported quality of life than subjects without COPD but had similar exercise, frequency of exacerbations, and indices of systemic effects.
BACKGROUND: The current debate about the lower limit of normal (LLN) vs the 0.7 fixed ratio to diagnose COPD is not completely resolved, and little information about the clinical impact of these different criteria is available. We compared differences in health-related quality of life, exacerbations, exercise tolerance, physical activity, comorbidity, and systemic biomarkers of subjects with FEV(1)/FVC < 0.7 but > LLN (ratio-only group) vs subjects without COPD and those with mild or moderate to severe COPD. METHODS: A population-based sample of 3,802 subjects aged 40 to 80 years from the Epidemiologic Study of COPD in Spain was selected. Subjects were evaluated with postbronchodilator spirometry, quality-of-life and physical activity questionnaires, and 6-min walk tests. Exacerbations within the previous year and comorbidities were recorded. Systemic biomarkers were measured after excluding subjects with conditions associated with systemic inflammatory processes. RESULTS: Fixed-ratio COPD overdiagnosis affects up to 4.6% of subjects aged 40 to 80 years, is more frequent in men, and increases with age. After adjusting for confounding factors, the ratio-only group had a worse health-related quality of life than the non-COPD group, with poorer scores in all questionnaire domains (P < .05). However, no differences between the two groups for respiratory exacerbations, 6-min walk distance, physical activity, or systemic biomarkers were observed. Ratio-only subjects did not present greater risk for cardiovascular disease (adjusted relative OR, 1.47; 95% CI, 0.81-2.64), whereas subjects with mild COPD did (adjusted relative OR, 2.32; 95% CI, 1.11-4.84). CONCLUSIONS: Subjects receiving a diagnosis of COPD by the fixed ratio present worse self-reported quality of life than subjects without COPD but had similar exercise, frequency of exacerbations, and indices of systemic effects.
Authors: Surya P Bhatt; Pallavi P Balte; Joseph E Schwartz; Patricia A Cassano; David Couper; David R Jacobs; Ravi Kalhan; George T O'Connor; Sachin Yende; Jason L Sanders; Jason G Umans; Mark T Dransfield; Paulo H Chaves; Wendy B White; Elizabeth C Oelsner Journal: JAMA Date: 2019-06-25 Impact factor: 56.272
Authors: Marko Topalovic; Vasileios Exadaktylos; Marc Decramer; Thierry Troosters; Daniel Berckmans; Wim Janssens Journal: Med Biol Eng Comput Date: 2014-09-30 Impact factor: 2.602
Authors: Surya P Bhatt; Jessica C Sieren; Mark T Dransfield; George R Washko; John D Newell; Douglas S Stinson; Gideon K D Zamba; Eric A Hoffman Journal: Thorax Date: 2013-03-23 Impact factor: 9.139
Authors: Reinier P Akkermans; Marvin A Berrevoets; Ivo J Smeele; Annelies E Lucas; Bart P Thoonen; Joke G Grootens-Stekelenburg; Yvonne F Heijdra; Chris van Weel; Tjard R Schermer Journal: BMC Pulm Med Date: 2012-03-22 Impact factor: 3.317
Authors: Kevin Jenniskens; Joris A H de Groot; Johannes B Reitsma; Karel G M Moons; Lotty Hooft; Christiana A Naaktgeboren Journal: BMJ Open Date: 2017-12-27 Impact factor: 2.692
Authors: Firdaus A A Mohamed Hoesein; Pim A de Jong; Jan-Willem J Lammers; Willem Pthm Mali; Michael Schmidt; Harry J de Koning; Carlijn van der Aalst; Matthijs Oudkerk; Rozemarijn Vliegenthart; Bram van Ginneken; Eva M van Rikxoort; Pieter Zanen Journal: PLoS One Date: 2013-06-13 Impact factor: 3.240